See the execution risk behind the scientific promise

RegulatoryX provides independent, decision-focused review of clinical and regulatory pathways, evidence gaps, organisational capability and the practical burden of the next value inflection.

Discuss your situation ↗See our services →

WORKING METHOD●

01Thesis

02Risk

03Value

FocusDecision-ready direction

QUESTIONS WE HELP ANSWER

Test the pathway before capital is committed

Pathway coherence

Is the proposed development pathway coherent, sequenced and realistically executable?

Material assumptions

Which regulatory assumptions are material to time, capital or probability of success?

Evidence alignment

Are dose, population, endpoint, biomarker and comparator choices genuinely aligned?

Capability gaps

Does the organisation have the leadership and specialist capacity for the next phase?

DILIGENCE OUTPUTS

From a rapid screen to a 100-day plan

Rapid issue screen ahead of deeper diligence
Independent programme diagnostic with a prioritised risk map
Structured management challenge session
A 100-day leadership and capability plan for after investment or transaction

START WITH THE CONSTRAINT

What is slowing your programme — or which capability is your team missing?

Tell us the decision, deliverable or role you are working through. We will help identify the most useful next step.

Start a conversation ↗Explore our services →